Does a mass spectrometry result prove the peptide sequence?

Not on its own. A single-stage mass measurement compares the observed molecular mass with the theoretical mass of the target compound, which is strong identity evidence. It cannot distinguish species that share the same mass, such as a scrambled sequence with the same amino-acid composition. Sequence-level confirmation needs tandem mass spectrometry or another sequencing method, so a COA showing only a mass match should not be described as sequence verified.

Does third-party HPLC and mass-spec testing mean a peptide is sterile?

No. Sterility, endotoxin, bioburden, elemental impurities and residual solvents are each measured by separate methods that a purity and identity certificate does not run. A COA reporting HPLC and mass spectrometry is evidence about chemical composition and identity only. Any other property must be tested and reported separately to be claimed.

How long does a peptide COA stay relevant?

A certificate describes the sample that was tested on the date it was tested. It is the upper bound on that batch's quality; storage, transport and handling after testing can only subtract from it. The document stays relevant as evidence about that batch, but it does not certify the condition of material that has since been through freeze-thaw cycles, ambient shipping legs or moisture exposure.

Shop by goal

Metabolic Research

GH-Axis Research

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Popular compounds

Research resources

What a Peptide COA Cannot Tell You

Q: Does 99% HPLC purity mean the vial is 99% peptide?

No. HPLC purity is normally an area percentage: the main peak divided by the total integrated peak area in that chromatogram. It describes the relative composition of what eluted and was detected. It is not a statement about how much of the powder in the vial is peptide by mass, because water, counterions and residual salts are not part of that calculation. Net peptide content is a separate measurement.

Most guidance on Certificates of Analysis is written to help you spot a bad one: no batch number, no chromatogram, no named laboratory, a logo where the data should be. That advice is sound, and we have written our share of it. But it leaves a second problem untouched.

What happens when the certificate is real ? Batch-specific, from an independent laboratory, with a chromatogram attached and a mass-spectrometry trace underneath it. A document like that is genuine evidence — and it is still evidence about a narrow set of questions. The failure mode is no longer forgery. It is over-reading: treating an honest answer to one question as an answer to four others that were never asked.

This piece maps the edges of the document. Not to undermine it — a batch COA is still the single most useful thing a supplier can hand a laboratory — but because knowing where the evidence stops is what keeps the rest of it trustworthy. If you want the other half of the picture first, start with how to read a peptide Certificate of Analysis.

1. Purity is an area percentage, not a mass percentage

Reverse-phase HPLC separates a sample by how strongly its components interact with the column and the mobile phase. A detector — usually UV at around 214 nm, where the peptide bond absorbs — records what comes off, and the software integrates the resulting peaks. The purity figure on the certificate is normally the area of the main peak divided by the total integrated area.

Read that sentence again, because everything in this section follows from it. The number describes the relative composition of what eluted and was detected . It is a ratio between peaks. It is not a claim about the contents of the vial by weight.

Lyophilised peptide powder is not pure peptide. It routinely contains:

Residual water — freeze-drying removes most of it, not all of it, and the amount varies with the cycle and the sequence.

Counterions — peptides purified by RP-HPLC with a trifluoroacetic acid modifier come off as TFA salts unless a salt exchange is performed. Acetate and hydrochloride forms are also common. The counterion is real mass in the vial.

Residual salts and buffer components from purification and formulation.

None of that appears in an area-percent calculation. Which is why net peptide content is a separate measurement, determined by amino-acid analysis, nitrogen determination or quantitative UV rather than by chromatography — and why it is commonly quoted in the 70–85% range for lyophilised material even when chromatographic purity is above 98%. Those two numbers are not in competition. They answer different questions, and a certificate that reports only the first has told you nothing about the second.

Why this matters in practice. Two vials, both labelled 10 mg, both with 99% HPLC purity certificates, can hold measurably different masses of actual peptide. For qualitative work that may not change a conclusion. For concentration-response curves, receptor-binding work, or any comparison between suppliers, it moves the x-axis under your data without announcing itself.

There is a second, quieter limit in the same measurement. Chromatography only reports what separates and what the detector sees. An impurity that co-elutes with the main peak is folded into it. A component that does not absorb meaningfully at the detection wavelength, or does not elute under the method's gradient, contributes nothing to the denominator. A 99% figure is 99% of what that method resolved , which is why the method details on a certificate are not boilerplate — they are the scope statement for the number above them.

2. A mass match is identity evidence, not a sequence map

Mass spectrometry earns its place on a COA. Comparing an observed molecular mass against the theoretical mass calculated from the intended sequence is a genuinely strong check, and a certificate that reports purity without it has skipped the more important half of the question. Purity without identity just tells you that you have a clean sample of something.

But a single-stage mass measurement establishes that the material has the expected mass. That is not the same as establishing that it has the expected sequence, because mass is not unique to one arrangement of residues.

A scrambled sequence built from the same amino acids has the same molecular formula and the same mass.

Leucine and isoleucine are isomers — identical in mass, and not separable by mass alone.

Certain residue transpositions and substitution pairs are mass-neutral or near enough to sit inside instrument tolerance.

Resolving those requires fragmentation — tandem mass spectrometry (MS/MS), which breaks the molecule and reads the fragment ladder — or a dedicated sequencing method. That is a different experiment, and it appears on a minority of research-market certificates.

The practical consequence is a language problem. “Identity confirmed by mass spectrometry” is accurate and useful. “Sequence verified” on a certificate whose only identity data is a single-stage mass measurement is a claim the underlying test does not support. When you see the stronger phrase, check which test is behind it.

3. The certificate is silent on everything it did not test

This is a common over-read in the research compound market, and it is entirely a scope error. HPLC answers a purity question. Mass spectrometry answers an identity question. Neither answers any of these:

Property What actually measures it On a purity/identity COA? Sterility Sterility testing under a compendial method No Bacterial endotoxin LAL or recombinant Factor C assay No Bioburden Microbial enumeration No Elemental impurities / heavy metals ICP-MS or ICP-OES No Residual solvents Headspace gas chromatography No Water content Karl Fischer titrimetry or loss on drying Only if reported Net peptide content Amino-acid analysis, nitrogen determination, quantitative UV Only if reported

“Third-party tested” is a statement about who ran a test . It says nothing about scope. Independence removes a conflict of interest, which is worth having, but it does not widen the method — an independent laboratory running HPLC has still only run HPLC. The phrase to be sceptical of is not “tested” but any adjective that quietly travels beyond the test: pure becomes clean, clean becomes safe, safe becomes suitable. Each of those steps needs its own data, and the honest documents say so on the page.

This is also where the pharmaceutical-grade versus research-grade distinction lives. A strong analytical result describes a material. Pharmaceutical status describes a regulated system of facilities, validated processes, quality management and oversight. No chromatogram converts one into the other.

4. It describes a sample on a date, not the vial in your hand

Testing happens at a point in the chain. Everything downstream of that point — packing, cold chain, customs holds, a courier leg at ambient temperature, a freezer that cycles, a stopper punctured and returned to storage — happens after the evidence was generated.

Peptides are chemically reactive in specific, sequence-dependent ways. Methionine, cysteine and tryptophan residues oxidise. Asparagine and glutamine deamidate. Multi-cysteine peptides can scramble disulfide bonds. Susceptible bonds hydrolyse, and some sequences aggregate. Lyophilisation slows this chemistry substantially by removing the water that drives much of it — which is exactly why research material ships freeze-dried — but it is a brake, not a stop.

The useful mental model: a COA is the upper bound on a batch's quality. Handling after the test can only subtract. That is not an argument against certificates; it is an argument for reading storage and transport as part of the same quality-control chain the certificate belongs to. See how to store peptides for the handling half.

5. It covers the batch it names — and only that batch

A certificate is scoped to a lot. That is the whole point of the lot number, and it is what separates analytical documentation from a marketing asset. It also means a certificate is silent about every other batch of the same compound, including the one that arrives next quarter from the same supplier.

A supplier who tested one batch in early 2026 and continues to attach that PDF to material from three subsequent production runs has not lied about anything on the document. The document is accurate. It is simply not evidence about the vial being shipped. The failure is scope creep, not forgery — which is why it survives a casual read.

Consistency is a separate property from purity, and it needs more than one data point to demonstrate. We have given it its own guide: peptide batch-to-batch consistency.

What to ask when the certificate stops answering

None of this argues for less documentation. It argues for reading the document at its actual resolution and asking for the rest explicitly:

Is the purity figure area percent? If so, what is the net peptide content, and how was it determined?

What method produced the number? Column, gradient, detection wavelength — the scope statement for the percentage.

Is the chromatogram attached , or only the integrated result?

What identity test was run , and does the wording match it — mass confirmation, or fragmentation?

What salt form is the material supplied in?

Does the lot number on the certificate match the vial label and the order record?

How old is the analysis relative to the batch you are receiving?

What was not tested — and is the supplier's copy claiming any of it anyway?

Why the margins widen as compounds get more complex

The analytical questions above were manageable when the research market was mostly short, unmodified sequences. That is no longer the shape of it. Interest in GLP-1 receptor pharmacology pulled in GIP and glucagon receptor work alongside it, and the compounds under study followed: dual and triple receptor agonists, lipidated and conjugated structures, non-standard residues, longer chains with more places for synthesis to go quietly sideways.

More elaborate molecules mean more closely related impurities, more co-elution risk, more mass-adjacent species, and more ways for a single chromatographic number to under-report what is present. The certificate does not get worse as compounds get harder — but the gap between what it measures and what you might assume it measures gets wider. Analytical literacy has to keep pace with the catalogue.

The bottom line

A Certificate of Analysis is not weakened by having limits. Every measurement has limits; documents that pretend otherwise are the ones to distrust. What a good COA gives you is a bounded, checkable, batch-scoped statement about identity and chromatographic purity, produced by a named method at a named laboratory on a named date.

Read at that resolution, it is the strongest evidence in the supply chain. Read as a general warranty of quality, purity by mass, sterility, sequence and present condition, it is being asked to carry four claims it never made. The suppliers worth trusting tend to be the ones who state the difference themselves — who say what the data shows and, just as clearly, what it does not.

Frequently Asked Questions

Does 99% HPLC purity mean the vial is 99% peptide? No. That figure is normally an area percentage — main peak over total integrated peak area. Water, counterions and residual salts sit outside the calculation entirely. Net peptide content is a separate assay, and for lyophilised material it is commonly well below the chromatographic figure.

Does a mass spectrometry result prove the sequence? Not on its own. It confirms the observed mass matches the theoretical mass, which is strong identity evidence, but scrambled sequences and isomeric residues such as leucine and isoleucine share that mass. Sequence-level confirmation needs tandem MS or another sequencing method.

Does third-party testing mean the material is sterile or endotoxin-free? No. Sterility, endotoxin, bioburden, elemental impurities and residual solvents each need their own method. A purity and identity certificate is evidence about chemical composition and identity, and about nothing else.

How long does a COA stay relevant? It remains accurate evidence about the batch and date it names. It is the upper bound on that batch's quality — storage, transport and handling after the test can only subtract, and it certifies nothing about a different lot.

Buy research peptides from New-U Research Compounds

Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. Research use only - all claims made on this site are for testing and research use only.

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research